Metalead
1 known investors
Find your way into Metalead
349 people in our graph share verified history with the Metalead team — schools, employers, funds. One of them is your warm intro.
Rutie Adarunlockedknows Michal Shoshan · together at Tel Aviv University (overlapped)
×2knows the team · via The Hebrew University of Jerusalem
×4knows the team · via ETH Zurich
×4knows the team · via Tel Aviv University
knows the team · via University of Zurich
metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.
Founders & leadership
MS
Michal ShoshaninFounder and CEOMichal Shoshan is founder and CEO of metaLead Therapeutics AG, a University of Zurich spin-off focused on metal-centered medicine. He holds background in medicinal inorganic chemistry and chemical biology.
Investors · 1
Frequently asked questions
- What does Metalead do?
- metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.
- Who founded Metalead?
- Metalead was founded by Michal Shoshan.
- Who are Metalead's investors?
- Metalead's investors include Kickfund.